Skip to main content
logo
Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
169.02
+8.52 (5.31%)
At close: Mar 31, 2026, 4:00 PM EDT
170.11
+1.09 (0.64%)
After-hours: Mar 31, 2026, 7:49 PM EDT

Axsome Therapeutics Revenue

In the year 2025, Axsome Therapeutics had annual revenue of $638.50M with 65.55% growth. Axsome Therapeutics had revenue of $196.00M in the quarter ending December 31, 2025, with 65.03% growth.

Revenue (ttm)
$638.50M
Revenue Growth
+65.55%
P/S Ratio
13.54
Revenue / Employee
$690,266
Employees
925
Market Cap
8.65B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025638.50M252.80M65.55%
Dec 31, 2024385.69M115.09M42.53%
Dec 31, 2023270.60M220.56M440.80%
Dec 31, 202250.04M--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BioMarin Pharmaceutical3.22B
Halozyme Therapeutics1.40B
Bio-Techne1.22B
Arrowhead Pharmaceuticals1.09B
Krystal Biotech389.13M
ImmunityBio113.29M
Cytokinetics88.04M
Praxis Precision Medicines7.46M
Revenue Rankings

AXSM News

More News